A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Trial Identifier: D601HC00006
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04959266
Start Date: June 2021
Primary Completion Date: June 2022
Study Completion Date: June 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish Translation
Spanish (US) Translation

Trial Locations

Country Location
ES Madrid, ES, 28041
US, OR Portland, OR, US, 97213
US, TX Austin, TX, US, 78758
US, TX Dallas, TX, US, 75230